- Home
- / Juvenescence
Juvenescence
Market Valuation
$500 M
2019-08-19
Total Funding
$162.3 M
Juvenescence Summary
Company Summary
- Overview
- Juvenescence is a biotech longevity company that develops therapies and products targeting aging. It operates through two divisions: JuvLife and JuvTherapeutics. JuvLife offers consumer products that manage aging and help increase healthspan. JuvTherapeutics focuses on traditional prescription medicines to modify aging and prevent diseases.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Dublin, IE | view all locations
- Website
- https://www.juvlabs.com/
- Cybersecurity rating
Table of Contents
Key People
Colin Watts, Chief Executive Officer, Juvenescence Life
Declan Doogan, Chief Medical Officer
David Roblin, Chief Executive Officer, JuvTherapeutics
LocationsView all
1 location detected
Dublin, D HQ
Ireland
88 Harcourt Street